Compared side by side

CJC-1295 with DAC vs ipamorelin: how they differ

Reviewed How we check the libraryPublished by PepVault

The short answer

They raise growth hormone through different receptors and on different clocks: CJC-1295 with DAC is a GHRH analogue whose DAC stretches its half-life to about a week, while ipamorelin is a ghrelin receptor agonist with a half-life of about 2 hours. One weekly injection of CJC-1295 with DAC keeps GH and IGF-1 raised for days; ipamorelin is taken 2–3 times a day and released GH without raising cortisol in animal studies. Neither was ever approved, and the human data for CJC-1295 with DAC are two small phase 1 studies.

Side by side

ComparedCJC-1295 with DACIpamorelin
CategoryGrowth hormoneGrowth hormone
Also known asCJC-1295 DAC, DAC:GRFIPAM
What it isA long-acting growth hormone releasing hormone analogue: the DAC modification extends its half-life to about a week, so one weekly injection keeps GH and IGF-1 raised, lifting baseline GH while natural pulses continue.Considered the 'cleanest' growth hormone stimulator: in animal studies it triggers the pituitary to release GH without raising cortisol, a side effect common with other GH peptides.
How it worksGHRH analogue with Drug Affinity Complex that extends half-life to about a week. In human studies one injection raised baseline GH and IGF-1 for days while natural GH pulses continued; recovery, body-composition and sleep effects are extrapolated from GH physiology and user reports. Weekly dosing protocol.Selective growth hormone secretagogue and ghrelin receptor agonist. In animal studies it released GH without raising cortisol or ACTH, and users report milder hunger than with GHRP-6. Considered one of the cleanest GH pulses available.
Commonly reportedWater retention and puffiness, sometimes tingling hands, over the first weeks, and tiredness in the days after the shot. Its human data are two small phase 1 studies; it was never approved.Deeper sleep and vivid dreams first, then better recovery, skin quality and gradual body-composition changes, with milder hunger than GHRP-6. Its human data are a small GH study and phase 2 trials in surgical patients; it was never approved.
Studied rangeResearch range: 1–2 mg. Studied in research — not a recommendation.Research range: 200–300 mcg, starting dose 200 mcg. Studied in research — not a recommendation.
How oftenWeekly2–3x daily, best fasted or before bed
Half-life~6–8 days (measured in healthy adults: 5.8–8.1 days)~2 hours (measured in healthy men, given IV)
RouteSubQ injectionSubQ injection, IM injection
Typical run8–12 weeks common. Weekly dosing means effects accumulate — give adequate time off between cycles.Commonly 8–12 weeks on, 4 weeks off to avoid receptor desensitisation. Some run longer with breaks.
EvidenceModerate: animal studies + some human dataModerate: animal studies + some human data
Common side effectsWater retention, headache, flushing, injection site pain, fatigue, carpal tunnel symptomsHeadache, flushing, nausea, water retention, numbness/tingling

Typical run: Community practice — opinions vary. Not a clinical recommendation.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Taking CJC-1295 with DAC or ipamorelin? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

CJC-1295 with DAC

  • Day 1–14 GH is building; water retention is common
  • Day 14–42 Recovery and skin quality are changing
  • Day 42–84 Peak recomp — watch for carpal tunnel

Every card for CJC-1295 with DAC, with its sources

Ipamorelin

  • Day 1–14 Sleep is deepening
  • Day 14–28 Recovery is noticeably faster
  • Day 28–56 Body composition shifts showing up
  • Day 56–84 Cycle-end + planned break

Every card for ipamorelin, with its sources

Together or one or the other

CJC-1295 with DAC and ipamorelin are a common stack: CJC-1295 with DAC lists ipamorelin among its common stacks.

Questions people ask

How long do CJC-1295 with DAC and ipamorelin last?

The half-life of CJC-1295 with DAC is ~6–8 days (measured in healthy adults: 5.8–8.1 days). The half-life of ipamorelin is ~2 hours (measured in healthy men, given IV).

How often are CJC-1295 with DAC and ipamorelin taken?

CJC-1295 with DAC: weekly. Route: SubQ injection. Ipamorelin: 2–3x daily, best fasted or before bed. Routes: SubQ injection, IM injection.

How are CJC-1295 with DAC and ipamorelin dosed in research?

The research range for CJC-1295 with DAC is 1–2 mg. The research range for ipamorelin is 200–300 mcg, with a 200 mcg starting dose. Studied in research — not a recommendation.

What are the common side effects of CJC-1295 with DAC and ipamorelin?

For CJC-1295 with DAC, the library lists: water retention, headache, flushing, injection site pain, fatigue, carpal tunnel symptoms. For ipamorelin: headache, flushing, nausea, water retention, numbness/tingling.

Are CJC-1295 with DAC and ipamorelin taken together?

CJC-1295 with DAC and ipamorelin are a common stack: CJC-1295 with DAC lists ipamorelin among its common stacks.

Each one in full

Track it in the app

PepVault for iPhone

Taking CJC-1295 with DAC or ipamorelin? Log it in PepVault

Each dose, each vial and your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo